Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.650
+0.001 (0.08%)
At close: Oct 24, 2024, 4:00 PM
0.630
-0.020 (-3.09%)
After-hours: Oct 24, 2024, 5:30 PM EDT
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $24.89 million as of October 24, 2024. Its market cap has decreased by -32.74% in one year.
Market Cap
24.89M
Enterprise Value
-29.94M
1-Year Change
-32.74%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $24.89M, a decrease of -96.40%. That is a compound annual growth rate of -59.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 24.90M | -41.41% |
| Dec 29, 2023 | 42.50M | -13.27% |
| Dec 30, 2022 | 49.00M | -73.18% |
| Dec 31, 2021 | 182.70M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Oncology Institute | 26.42M |
| SAB Biotherapeutics | 26.30M |
| ATI Physical Therapy | 26.27M |
| Akari Therapeutics, | 25.50M |
| KALA BIO | 25.48M |
| Tonix Pharmaceuticals Holding | 25.20M |
| iBio, Inc. | 24.96M |
| Pluri | 24.94M |